Quinine has been effective in some trials but is no longer recommended because of occasional serious adverse effects (eg, arrhythmias, thrombocytopenia, thrombotic thrombocytopenic purpura [TTP] and hemolytic-uremic syndrome [HUS], severe allergic reactions).